Picture of Immuron logo

IMC — Immuron News Story

0.000.00%
au flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapNeutral

Brief: Immuron Commences Travelan Clinical Study Cohort 2

Oct 18 (Reuters) - Immuron Ltd  IMC.AX :
    * IMMURON ANNOUNCES TRAVELAN® CLINICAL STUDY COHORT 2
COMMENCES
    * IMMURON ANNOUNCES TRAVELAN® CLINICAL STUDY COHORT 2
COMMENCES
    * IMMURON LTD - SECOND COHORT OF 34 HEALTHY VOLUNTEERS
ENROLLED IN
TRAVELAN(®) CLINICAL TRIAL
    * IMMURON LTD - HEADLINE RESULTS FROM CLINICAL TRIAL ARE
ANTICIPATED TO BE REPORTED IN JUNE 2024
    * IMMURON LTD - INPATIENT PHASE FOR SECOND COHORT WILL BE
COMPLETED BY END OF OCTOBER 2023

Source text for Eikon:  ID:nGNX6NrcjG 
Further company coverage:  IMC.AX 

 ((reuters.briefs@thomsonreuters.com;))

Recent news on Immuron

See all news